Related Experiment Video
Updated: Jun 12, 2026

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
Coronary angiography is a better predictor of mortality than noninvasive testing in patients evaluated for renal
Sean A Enkiri1, Angela M Taylor, Ellen C Keeley
1Department of Medicine, University of Virginia, Charlottesville, Virginia, USA.
Insights
For patients with end-stage renal disease (ESRD) awaiting transplantation, coronary angiography accurately identifies coronary artery disease (CAD) and predicts mortality, unlike noninvasive imaging.
Area of Science:
- Cardiology
- Nephrology
- Transplant Medicine
Background:
- Coronary artery disease (CAD) is a primary cause of mortality in end-stage renal disease (ESRD) patients.
- Optimal CAD identification methods for ESRD patients undergoing transplantation evaluation are debated.
- Limited prognostic data exists comparing noninvasive tests to coronary angiography in this population.
Purpose of the Study:
- To compare the accuracy of coronary angiography versus noninvasive imaging in identifying CAD.
- To determine which method better predicts mortality in ESRD patients evaluated for transplantation.
Main Methods:
- A cohort of 57 patients underwent both coronary angiography and stress perfusion imaging.
- Severe CAD was defined as ≥70% stenosis on angiography or ischemia in ≥1 zone on noninvasive testing.
- All-cause mortality was tracked for 3.3 years.
Main Results:
- Noninvasive imaging revealed ischemia in 63% of patients; angiography showed severe CAD in 40%.
- Noninvasive imaging demonstrated poor specificity (24%) and positive predictive value (43%) for severe CAD.
- Angiography, but not noninvasive imaging, predicted survival (3-year survival: 50% with severe CAD vs. 73% without).
Conclusions:
- False positive results from scintigraphy limited noninvasive imaging utility in ESRD patients.
- Coronary angiography proved a superior predictor of mortality compared to noninvasive testing in this cohort.
Objectives:
The goal of this study was to compare whether coronary angiography or noninvasive imaging more accurately identifies coronary artery disease (CAD) and predicts mortality in patients with end-stage renal disease (ESRD) under evaluation for transplantation.
Background:
CAD is a leading cause of mortality in patients with ESRD. The optimal method for identifying CAD in ESRD patients evaluated for transplantation remains controversial with a paucity of prognostic data currently available comparing noninvasive methods to coronary angiography.
Methods:
The study cohort consisted of 57 patients undergoing both coronary angiography and stress perfusion imaging. Severe CAD was defined by angiography as ≥ 70% stenosis, and by noninvasive testing as ischemia in ≥ 1 zone. Follow-up for all cause mortality was 3.3 years.
Results:
On noninvasive imaging, 63% had ischemia. On angiography, 40% had at least one vessel with severe stenoses. Abnormal perfusion was observed in 56% of patients without severe disease angiographically. Noninvasive imaging had poor specificity (24%) and poor positive predictive value (43%) for identifying severe disease. Angiography but not noninvasive imaging predicted survival; 3 year survival was 50% and 73% for patients with and without severe CAD by angiography (p<0.05).
Conclusions:
False positive scintigrams limited noninvasive imaging in patients with ESRD. Angiography was a better predictor of mortality compared with noninvasive testing.
Related Concept Videos
Imaging Studies VII: Vascular Imaging
Kidney Transplant I: Introduction
Acute Coronary Syndrome III: Diagnostic Studies
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Imaging Studies for Cardiovascular System V: CT
Cardiac Catheterization I: Pre-Procedure Overview

